β-arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioids

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 8, 2005, Pages 3034-3039

  Bradaïa, Amyaouch ^a   Berton, Frédérique ^a   Ferrari, Serge ^a   Lüscher, Christian ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

opioid receptors; Analgesia; Locus coeruleus periaqueductal gray; Synaptic transmission

Indexed keywords

BETA ARRESTIN; BETA ARRESTIN 2; CYCLIC AMP; FENTANYL; G PROTEIN COUPLED RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; OPIATE; PHOSPHODIESTERASE IV; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; KNOCKOUT MOUSE; LOCUS CERULEUS; MOUSE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; POTASSIUM CURRENT; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SYNAPSE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; ARRESTINS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FENTANYL; GAMMA-AMINOBUTYRIC ACID; LOCUS COERULEUS; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MORPHINE; NEURAL INHIBITION; PROBABILITY; SYNAPTIC TRANSMISSION;

EID: 14544269885     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0406632102     Document Type: Article

References (40)

1. Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J. & Caron, M. G. (2004) Annu. Rev. Neurosci. 27, 107-144.
2. Conti, M., Richter, W., Mehats, C., Livera, G., Park, J. Y. & Jin, C. (2003) J. Biol. Chem. 278, 5493-5496.
3. Houslay, M. D. & Adams, D. R. (2003) Biochem. J. 370, 1-18.
4. Perry, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., Miller, W. E., McLean, A. J., Conti, M., Houslay, M. D. & Lefkowitz, R. J. (2002) Science 298, 834-836.
5. Baillie, G. S., Sood, A., McPhee, I., Gall, I., Perry, S. J., Lefkowitz, R. J. & Houslay, M. D. (2003) Proc. Natl. Acad. Sci. USA 100, 940-945.
6. Bolger, G. B., McCahill, A., Huston, E., Cheung, Y. F., McSorley, T., Baillie, G. S. & Houslay, M. D. (2003) J. Biol. Chem. 278, 49230-49238.
7. Whistler, J. L. & von Zastrow, M. (1998) Proc. Natl. Acad. Sci. USA 95, 9914-9919.
8. Bohn, L. M., Dykstra, L. A., Lefkowitz, R. J., Caron, M. G. & Barak, L. S. (2004) Mol. Pharmacol. 66, 106-112.
9. Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G. & Lin, F. T. (1999) Science 286, 2495-2498.
10. Pan, Y. Z., Li, D. P., Chen, S. R. & Pan, H. L. (2004) Brain Res. 997, 67-78.
11. Torrecilla, M., Marker, C. L., Cintora, S. C., Stoffel, M., Williams, J. T. & Wickman, K. (2002) J. Neurosci. 22, 4328-4334.
12. Lüscher, C., Jan, L. Y., Stoffel, M., Malenka, R. C. & Nicoll, R. A. (1997) Neuron 19, 687-695.
13. Miller, R. J. (1998) Annu. Rev. Pharmacol. Toxicol. 38, 201-227.
14. Scanziani, M., Capogna, M., Gahwiler, B. H. & Thompson, S. M. (1992) Neuron 9, 919-927.
15. Vaughan, C. W., Ingram, S. L., Connor, M. A. & Christie, M. J. (1997) Nature 390, 611-614.
16. Cohen, G. A., Doze, V. A. & Madison, D. V. (1992) Neuron 9, 325-335.
17. Jones, S. L. & Gebhart, G. F. (1986) J. Neurophysiol. 56, 1397-1410.
18. Fields, H. (2004) Nat. Rev. Neurosci. 5, 565-575.
19. Osborne, P. B., Vaughan, C. W., Wilson, H. I. & Christie, M. J. (1996) J. Physiol. 490, 383-389.
20. Blanchet, C. & Lüscher, C. (2002) Proc. Natl. Acad. Sci. USA 99, 4674-4679.
21. Blanchet, C., Sollini, M. & Luscher, C. (2003) Mol. Cell. Neurosci. 24, 517-523.
22. Cruz, H. G., Ivanova, T., Lunn, M. L., Stoffel, M., Slesinger, P. A. & Lüscher, C. (2004) Nat. Neurosci. 7, 153-159.
23. Osborne, P. B. & Williams, J. T. (1995) Br. J. Pharmacol. 115, 925-932.
24. Bailey, C. P., Couch, D., Johnson, E., Griffiths, K., Kelly, E. & Henderson, G. (2003) J. Neurosci. 23, 10515-10520.
25. Stuart, G. J. & Redman, S. J. (1991) Neurosci. Lett. 126, 179-183.
26. Vaughan, C. W. & Christie, M. J. (1997) J. Physiol. (London) 498, 463-472.
27. Reeves, M. L., Leigh, B. K. & England, P. J. (1987) Biochem. J. 241, 535-541.
28. Chavez-Noriega, L. E. & Stevens, C. F. (1994) J. Neurosci. 14, 310-317.
29. Weisskopf, M. G., Castillo, P. E., Zalutsky, R. A. & Nicoll, R. A. (1994) Science 265, 1878-1882.
30. Nagy, G., Reim, K., Matti, U., Brose, N., Binz, T., Rettig, J., Neher, E. & Sorensen, J. B. (2004) Neuron 41, 417-429.
31. Kaneko, M. & Takahashi, T. (2004) J. Neurosci. 24, 5202-5208.
32. Beavo, J. A. & Brunton, L. L. (2002) Nat. Rev. Mol. Cell. Biol. 3, 710-718.
33. Sakaba, T. & Neher, E. (2003) Nature 424, 775-778.
34. Hack, S. P., Vaughan, C. W. & Christie, M. J. (2003) Neuropharmacology 45, 575-584.
35. Ingram, S. L., Vaughan, C. W., Bagley, E. E., Connor, M. & Christie, M. J. (1998) J. Neurosci. 18, 10269-10276.
36. Mitrovic, I., Margeta-Mitrovic, M., Bader, S., Stoffel, M., Jan, L. Y. & Basbaum, A. I. (2003) Proc. Natl. Acad. Sci. USA 100, 271-276.
37. Minnis, J. G., Patierno, S., Kohlmeier, S. E., Brecha, N. C., Tonini, M. & Sternini, C. (2003) Neuroscience 119, 33-42.
38. Nicholson, D., Reid, A. & Sawynok, J. (1991) Pharmacol. Biochem. Behav. 38, 753-758.
39. Robichaud, A., Stamatiou, P. B., Jin, S. L., Lachance, N., MacDonald, D., Laliberte, F., Liu, S., Huang, Z., Conti, M. & Chan, C. C. (2002) J. Clin. Invest. 110, 1045-1052.
40. O'Donnell, J. M. & Zhang, H. T. (2004) Trends Pharmacol. Sci. 25, 158-163.